Implant for intraocular drug delivery

A method of treating an inflammatory or degenerative disease in or around the eye, comprising the steps of:

• a. providing to the eye an eye implant, the eye implant comprising:
• i. an effective amount of at least one therapeutic agent, the at least one therapeutic agent comprising at least one anti-TNFα antibody, nanobody, antibody fragment, or combination thereof;
• anti-interleukine-1 antibody, nanobody, antibody fragment, or combination thereof;
• anti-interleukine-6 antibody, nanobody, antibody fragment, or combination thereof;
• anti-interleukine-12 antibody, nanobody, antibody fragment, or combination thereof;
• or a combination thereof;
• and
• ii. a coating or encapsulating material that coats or encapsulates the at least one therapeutic agent and stabilizes the at least one therapeutic agent;
• b. implanting the eye implant in an eye of a living subject, wherein the effective amount of at least one therapeutic agent is releasable to the environment of the eye implant over an extended period of time.